Vipivotide Tetraxetan PSMA-617 | 2 mg Peptide

Vipivotide tetraxetan (PSMA-617) - CAS 1702967-37-0

US$2,737.24

Excluding tax and shipping fees

In stock

Description

About Vipivotide tetraxetan (PSMA-617) - CAS 1702967-37-0

Vipivotide tetraxetan (PSMA-617) - CAS 1702967-37-0, precursor for radiolabeled PSMA-617 and with high affinity for the prostate-specific membrane antigen (PSMA). Can be bound to radionuclides for development of cancer treatment and diagnosis. For research use only!

Vipivotide tetraxetan (PSMA-617) - CAS 1702967-37-0 - Specifications

Peptide sequence: Glu-urea-Lys(DOTA-4AMCHC-2Nal)-OH (4AMCHC = 4-aminomethylcyclohexanoic acid - 2Nal = 2-naphthylalanine

Amount: 2 mg (20 x100µg)

Purity: >95% (HPLC-MS)

Delivery Format: Freeze-dried in plastic vial

CAS: 1702967-37-0

Application(s): Nuclear medicine

Condition(s)/Topic(s): Cancer

Standard Delivery Time: approx. 3 weeks

We provide the peptide in a range of aliquot sizes, ensuring flexibility for diverse research applications. For any special requirements, please contact our customer support: [email protected]

JPT’s Oncology Peptides

One focus of JPT’s product development is oncology. Therefore, we offer a huge variety of TAA peptide, peptide pools and microarrays, as well as DOTA peptides and radio sensitizers. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides in all formats, scales and modifications to the global scientific community. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.Have a look at our Peptide Tools to Study Cancer.

Benefits of JPT's Single Catalogue Peptides - Synthesis protocols designed to avoid toxic contaminants and side products - Provision of freeze dried aliquots for enhanced stability - Proven track record for applications in clinical studies

References

References for Vipivotide tetraxetan (PSMA-617) - CAS 1702967-37-0

References:Read References with Specialty Peptides

Documentation

Documentation for Vipivotide tetraxetan (PSMA-617) - CAS 1702967-37-0

Vipivotide-tetraxetan-PSMA-617-CAS-1702967-37-0-3.pdf

Properties

Properties of Vipivotide tetraxetan (PSMA-617) - CAS 1702967-37-0

Nuclear medicine

Chelate Peptides (DOTA)

Cancer

Freeze-dried in plastic vial

Artificial

Other

>95% (HPLC-MS)

No

Further Information to Vipivotide tetraxetan (PSMA-617) - CAS 1702967-37-0

Values

Glu-urea-Lys(DOTA-4AMCHC-2Nal)-OH (4AMCHC = 4-aminomethylcyclohexanoic acid - 2Nal = 2-naphthylalanine Copy Sequence Show complete Sequence Show trimmed Sequence

Vipivotide tetraxetan (PSMA-617)

Related Products

Related Products

NOTA-AMBA - Radioligand

US$2,052.93

PSMA I&T - Radioligand

US$4,179.76

DOTA-cyclo(RGDfK) - CAS 909024-55-1

US$1,021.11